Growing Academic-Industry Research Partnerships

Biomedical Sciences Industry Partnership Office

The mission of Biomedical Sciences Industry Partnership Office (BMSIPO) is to catalyse academic-industry research and clinical partnerships across Singapore’s ecosystem, helping businesses grow and deliver innovative healthcare solutions.

What Sets Us Apart

BMSIPO specialises in understanding our industry partners’ research and development interests, bringing together groups with the right capabilities, and crafting win-win collaboration models.

Since our inception as a publicly-funded national platform in 2010, we have been forging strategic alliances that foster research and development (R&D) and clinical partnerships between industry partners and public research and healthcare institutions in Singapore.

Tailored Solutions For All

Whether you’re a nimble Singapore startup or multi-national corporation with global networks, BMSIPO is your strategic ally.

We take pride in developing partnerships that encompass the entire spectrum of R&D – from discovery research to technology development, pre-clinical to clinical development, translational clinical studies, and even manufacturing and process technology development. BMSIPO can be your strategic partner to help advance your R&D roadmap like never before.

Learn More

What Our Partners Say

BMSIPO has been a tremendous support to Singapore Translational Cancer Consortium’s mission. Their networks to industry partners both international and in Singapore, and experience in structuring collaboration agreements has helped STCC accelerate our efforts.

Professor Chng Wee Joo
Executive Director, STCC

BMSIPO has been an invaluable partner to CPR and their unwavering support has been instrumental in accelerating collaborative research with the local scientific environment, especially for the dengue and COVID-19 projects with A*STAR. We’re confident that our continued interactions with BMSIPO will yield greater future successes.

Dr Hideaki Shimada
CEO of Chugai Pharmabody Research (CPR), a wholly-owned subsidiary of Chugai Pharmaceutical

TRUST is appreciative of BMSIPO’s support to the research community. As the national data sharing and analytics platform for health-biomedical research, we value the partnership with BMSIPO to enable cutting-edge data driven innovations and partnerships for the benefit of our society.

Mingshi Koh
Director, TRUST Office

RECISE has benefited immensely from BMSIPO’s collective knowledge and experience in forging multi-institutional research projects and long-term strategic partnerships with the pharmaceutical and biomedical industry. We look forward to continuing our fruitful collaboration with BMSIPO to drive innovation and shape the future of healthcare.

Professor Patrick Tan
Executive Director, PRECISE

Updates

Powering Partnerships, Building for Impact

BMSIPO celebrates 15 years of advancing biomedical innovation
Learn More

Ushering in the Next Generation of Cell Therapies in Singapore

Elpis Biopharmaceuticals and Singapore General Hospital are joining forces to develop effective and accessible next generation cancer therapies.
Learn More

Targeting Acne at Its Root

Sanofi is advancing a microbiome-based acne vaccine in partnership with A*STAR and the National Healthcare Group to flip how acne is treated on its head.
Learn More

FY2025 HHP I&E Workplan Sharing Workshop

Public sector ecosystem stakeholders gathered to share their plans for FY2025 and thoughts on the proposed RIE2030 HHP EVC strategy
Learn More

Managing Cross-Border Data Flows in Biomedical Research Collaborations with EU/UK Partners 

Public sector stakeholders gathered to explore cross-border data flow management in biomedical research collaborations
Learn More

Leveraging Innovation to Improve Global Health

Supported by Singapore’s research ecosystem, Eli Lilly expands its R&D efforts in the region to drive next-generation AI-powered digital health technology research.
Learn More

Our Partners